CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Frontier Biotechnologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Frontier Biotechnologies Inc
Hi-Tech Park, Jiangning District
Phone: +86 2569648375p:+86 2569648375 NANJING, JNG  211199  China Ticker: 688221688221
Business Summary
Frontier Biotechnologies Inc is a China-based company principally engaged in the research and development, production, and sales of drugs. The Company's products mainly include long-acting anti-human immunodeficiency virus (HIV) drugs, small nucleic acid drugs, and high-end generics. The long-acting anti-HIV drugs mainly include Aikoning. The small nucleic acid drugs mainly include FB7011, FB7013, and FB7014 and others. The high-end generics mainly include FB4001 and FB3002 and others. The Company's drugs are mainly used for the treatment of acquired immune deficiency syndrome (AIDS), abnormal blood lipids, and osteoporosis.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

General Information
Number of Employees: 302 (As of 12/31/2024)
Outstanding Shares: 374,578,653 (As of 6/30/2025)
Shareholders: 11,879
Stock Exchange: SHA
Fax Number: +86 2569748373


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, September 26, 2025